Professional Role and Tenure
Aaron Nelson has served as Chief Medical Officer (CMO) at MIM Software Inc. since at least January 2017, with an overall tenure at the company spanning nearly 20 years (since December 2005) in various medical leadership roles including Medical Director. This long-standing association indicates deep institutional knowledge and leadership within the company’s clinical and scientific endeavors.
Responsibilities and Expertise
Aaron’s role as CMO entails overseeing clinical science aspects of MIM Software’s portfolio, which provides innovative software solutions across multiple imaging specialties: Radiation Oncology, Nuclear Medicine, Radiology, Interventional Radiology, Molecular Imaging, Neuroimaging, and Cardiac Imaging. His expertise includes but is not limited to:
- Radiation Therapy
- Medical Imaging and Image Analysis
- Computed Tomography
- Practical and accurate dosimetry applications in molecular radiotherapies
He is an active voice in advancing dosimetry standards and molecular radiotherapy software, as exemplified by his leadership in MIM Software's SurePlan™ MRT product, which has become a recognized standard in Radiation Particle Therapy (RPT) centers of excellence.
Academic and Research Affiliations
Aaron Nelson holds an adjunct appointment as Assistant Professor in the Department of Biomedical Engineering at Case School of Engineering (Case Western Reserve University). This academic linkage underscores his active involvement in biomedical research and education alongside his executive role.
His research profile includes involvement in technical developments and clinical validation studies aimed at improving diagnostic accuracy and treatment planning in oncology imaging, including contributions to:
- Quantitative software methods improving (18)F FDG PET diagnostics
- Multi-atlas segmentation approaches for lung cancer imaging
- Frameworks for deformable image registration quality assurance
- Standardization of amyloid PET imaging using the Centiloid scale
Aaron’s participation in peer-reviewed publications and conference presentations highlights his contribution to advancing imaging technologies within medical oncology and molecular therapy disciplines.
Notable Collaborations and Industry Impact
He has played a key role in strategic collaborations with leading cancer centers, such as the Peter MacCallum Cancer Centre, aimed at developing reproducible and standardized patient management tools for prostate cancer and other oncology applications.
Under his clinical leadership, MIM Software achieved regulatory milestones including:
- FDA clearance of SurePlan molecular radiotherapy software that enables broader accessibility without the need for specialized hardware
- CE Mark approval, facilitating European market access for molecular radiotherapy software solutions
These achievements demonstrate Aaron’s contribution to both product development and compliance strategies critical for global market expansion.
Education and Professional Credentials
Aaron Nelson earned his MD from the Medical College of Ohio (1997-2001) and has cultivated a strong skill set in leadership, project management, and strategic planning applicable to managing clinical software development and commercialization in an evolving regulatory landscape.
Location and Network
Based in Beachwood, Ohio, Aaron maintains an active LinkedIn profile with over 340 professional connections, reflecting a well-established network within medical imaging and healthcare technology communities.
Aaron Nelson’s longstanding clinical leadership, academic engagement, and active participation in regulatory and collaborative initiatives position him as a pivotal figure in the advancement of MIM Software’s innovative imaging solutions, particularly in radiation oncology and molecular radiotherapies. His expertise and involvement in product standardization and regulatory clearance efforts demonstrate a focus on clinical efficacy and regulatory compliance—key considerations for technology adoption in complex healthcare environments.
